US FDA GRANTS ACCELERATED APPROVAL TO ASTRAZENECA'S ETCAMAH FOR ADVANCED BREAST CANCER WITH ESR1 MUTATION(@FirstSquaw)t.me/firstsquaw/173022September 4, 2026 131 1